CLPT.NASDAQClearpoint Neuro, INC

Form 4: ClearPoint Neuro Executive Settles Restricted Stock Units, Disposes of Shares for Tax Obligations

Sentiment:

SEC Form 4 Filing

📋All filings for Clearpoint Neuro, INC
🔒Login to Follow

Jeremy L. Stigall, Chief Business Officer of ClearPoint Neuro, Inc., settled restricted stock units for shares and disposed of shares to cover tax obligations on March 12, 2025.

Summary

  • On March 12, 2025, Jeremy L. Stigall, the Chief Business Officer of ClearPoint Neuro, Inc. (CLPT), settled 15,497 restricted stock units, receiving an equivalent number of common stock shares.
  • Stigall also disposed of 5,545 shares of common stock at a price of $13.18 to satisfy tax withholding obligations related to the vesting of the restricted stock units.
  • Following these transactions, Stigall directly owns 74,308 shares of ClearPoint Neuro common stock and 61,990 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider transactions, with no inherent positive or negative implications for the company's performance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It is a standard practice for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

  • The transactions have a minimal impact on stakeholders, as they are related to routine executive compensation and tax obligations.

Key Dates

DateDescription
03/12/2025Date of transaction: settlement of restricted stock units and disposal of shares for tax obligations.
03/14/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.